SSShravya Singh

Shravya Singh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shravya Singh has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Advanced liver fibrosis detection using a two-stage deep learning approach on standard T2-weighted MRI

    by Pankaj Gupta, Shravya Singh, Ajay Gulati, Niharika Dutta, Yashika Aggarwal, Naveen Kalra, Madhumita Premkumar, Sunil Taneja, Nipun Verma, Arka De, et al.

    Objectives To develop and validate a deep learning model for automated detection of advanced liver fibrosis using standard T2-weighted MRI. Methods We utilized two datasets: the public CirrMRI600 + dataset (n = 374) containing T2-weighted MRI scans from patients with cirrhosis (n = 318) and healthy subjects (n = 56), and an in-house dataset of chronic liver disease patients (n = 187). A two-stage deep learning pipeline was developed: first, an automated liver segmentation model using nnU-Net architecture trained on CirrMRI600 + and then applied to segment livers in our in-house dataset; second, a Masked Attention ResNet classification model. For classification model training, patients with liver stiffness measurement (LSM) > 12 kPa were classified as advanced fibrosis (n = 104). In contrast, healthy subjects from CirrMRI600 + and patients with LSM ≤ 12 kPa were classified as non-advanced fibrosis (n = 116). Model validation was exclusively performed on a separate test set of 23 patients with histopathological confirmation of the degree of fibrosis (METAVIR ≥ F3 indicating advanced fibrosis). We additionally compared our two-stage approach with direct classification without segmentation, and evaluated alternative architectures including DenseNet121 and SwinTransformer. Results The liver segmentation model performed excellently on the test set (mean Dice score: 0.960 ± 0.009; IoU: 0.923 ± 0.016). On the pathologically confirmed independent test set (n = 23), our two-stage model achieved strong diagnostic performance (sensitivity: 0.778, specificity: 0.800, AUC: 0.811, accuracy: 0.783), significantly outperforming direct classification without segmentation (AUC: 0.743). Classification performance was highly dependent on segmentation quality, with cases having excellent segmentation (Score 1) showing higher accuracy (0.818) than those with poor segmentation (Score 3, accuracy: 0.625). Alternative architectures with masked attention showed comparable but slightly lower performance (DenseNet121: AUC 0.795; SwinTransformer: AUC 0.782). Conclusions Our fully automated deep learning pipeline effectively detects advanced liver fibrosis using standard non-contrast T2-weighted MRI, potentially offering a non-invasive alternative to current diagnostic approaches. The segmentation-first approach provides significant performance gains over direct classification.


  • Radiological signature of HER2-Positive gallbladder cancer: analysis of CT features

    by Pankaj Gupta, Niharika Dutta, Shravya Singh, Nikita Pradhan, Ruby Siddiqui, Ajay Gulati, Naveen Kalra, Gaurav Prakash, Thakur Yadav, Lileswar Kaman, et al.

    Objective This study aimed to identify distinctive computed tomography (CT) features associated with human epidermal growth factor receptor 2 (HER2) status in gallbladder cancer (GBC) that could serve as noninvasive imaging biomarkers. Materials and methods This study included 213 patients with pathologically confirmed GBCs with availability of HER2 status (171 HER2-negative, 42 HER2-positive). Pre-treatment contrast-enhanced CT scans were evaluated by two radiologists blinded to HER2 status. Multivariate analysis was performed using logistic regression with L2 regularization. Model discrimination was assessed using receiver operating characteristic (ROC) analysis, and internal validation was performed using bootstrap resampling (1,000 iterations) to correct for optimism. Results HER2-positive tumors exhibited larger lymph nodes (1.93 ± 0.79 cm vs. 1.61 ± 0.61 cm, p = 0.015), less frequent gallstones (14.3% vs. 35.7%, p = 0.013), arterial phase hyperenhancement (20.0% vs. 44.1%, p = 0.026), mass-like morphology (35.7% vs. 55.6%, p = 0.033), and more frequent biliary compression by lymph nodes (19.0% vs. 4.1%, p = 0.002). Multivariate analysis identified biliary compression by lymph nodes as the strongest positive predictor of HER2 positivity [odds ratio (OR) 2.99, 95% CI: 1.25–7.04], while arterial phase hyperenhancement (OR 0.40, 95% CI: 0.19–0.75), gallstone presence (OR 0.40, 95% CI: 0.18–0.75), and mass-like morphology (OR 0.54, 95% CI: 0.29–0.95) were significant negative predictors. The model demonstrated good discrimination (area under the ROC curve 0.782) with sensitivity 75%, specificity 79.4%, and negative predictive value 96.2%. Conclusion HER2-positive GBCs display characteristic CT findings that can be utilized for noninvasive diagnosis with robust predictive performance.


  • Deep learning-based segmentation of gallbladder cancer on abdominal computed tomography scans: a multicenter study

    by Pankaj Gupta, Niharika Dutta, Ajay Tomar, Shravya Singh, Sonam Choudhary, Nandita Mehta, Vansha Mehta, Rishabh Sheth, Divyashree Srivastava, Salai Thanihai, et al.